Search

Aim: Cow's milk protein allergy (CMPA) in the infant is shown to be associated with heightened anxiety in the parents. However, depression and coping styles were not studied in parents of children with CMPA. The object of this study was to investigate the internalizing problems and coping styles in mothers of youngsters with CMPA. Materials and Methods: The sample contained 41 subjects with CMPA and 41 subject without any chronic health problems, aged between 4 and 11 months. Anxiety, depression and coping styles of mothers were measured with Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI) and Coping Attitudes Rating Scale (COPE). Results: There were significant differences between the two groups in terms of anxiety and depression levels (p< 0.001). The mothers in the CMPA group used active emotional coping strategies less than control group (p=0.021). Total breastfeeding duration of the children in the CMPA group was lower than the healthy controls (p=0.008). There was negative correlation between active emotional coping scores and the time of adding supplemental food to infant's diet (r=-0.42, p=0.06). Children who had additional food allergies breastfed less than the children who had only CMPA (p=0.02). Conclusion: Mothers of the children with CMPA are under heightened risk for anxiety and depression. Children with CMPA may be at risk for shorter duration of breastfeeding. Anxious and depressed caregivers may be referred for psychological help since the first year of life is essential for healthy psychological development of the children. [ABSTRACT FROM AUTHOR]

Aim: The purpose of this study was to compare the results of L-dopa and clonidine GH stimulation tests in children with short stature and to identify which of these should be primarily selected. Materials and Methods: The records of 68 patients aged between 2.5 and 16.6 years presenting to the pediatric endocrinology clinic with short stature and undergoing GH stimulation tests between September 2016 and February 2021 were evaluated retrospectively. Cases with GH levels <10 ng/ml following the first GH stimulation test then underwent the other GH stimulation test. Thirty-four (50%) of the cases in the study began with the clonidine test and the other 34 (50%) with the L-dopa test. Results: Thirty-five patients (51.5%) were girls and 33 (48.5%) were boys. The clonidine test results were also low in 35 of the 44 patients with peak GH levels <10 ng/ml at the L-dopa test. L-dopa test results were similarly low in 35 of the 37 patients with clonidine test results <10 ng/ml. Chi-square analysis revealed a statistically significant difference between the groups in terms of L-dopa and clonidine measurements (p< 0.001). A cut-off point of 8.9 ng/ml was determined for 50% sensitivity and 100% specificity for the L-dopa test, and a cut-off point of 9.76 for 88% sensitivity and 94% specificity for the clonidine test. Conclusion: GH stimulation tests performed to investigate GHD are laborious and timeconsuming. The first stimulation test to be applied to differentiate GHD from ISS must therefore be well selected. The clonidine stimulation test, with higher sensitivity than but similar specificity to the L-dopa test, can be employed as the first test. [ABSTRACT FROM AUTHOR]